Global transcription in pluripotent embryonic stem cells S Efroni, R Duttagupta, J Cheng, H Dehghani, DJ Hoeppner, C Dash, ... Cell stem cell 2 (5), 437-447, 2008 | 816 | 2008 |
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 ID Mascanfroni, A Yeste, SM Vieira, EJ Burns, B Patel, I Sloma, Y Wu, ... Nature immunology 14 (10), 1054-1063, 2013 | 386 | 2013 |
Rep‐Seq: uncovering the immunological repertoire through next‐generation sequencing J Benichou, R Ben‐Hamo, Y Louzoun, S Efroni Immunology 135 (3), 183-191, 2012 | 313 | 2012 |
Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation S Efroni, D Harel, IR Cohen Genome research 13 (11), 2485-2497, 2003 | 206 | 2003 |
The linker histone H1. 0 generates epigenetic and functional intratumor heterogeneity CM Torres, A Biran, MJ Burney, H Patel, T Henser-Brownhill, AHS Cohen, ... Science 353 (6307), aaf1644, 2016 | 179 | 2016 |
Identification of key processes underlying cancer phenotypes using biologic pathway analysis S Efroni, CF Schaefer, KH Buetow PloS one 2 (5), e425, 2007 | 159 | 2007 |
Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma RJ Clifford, J Zhang, DM Meerzaman, MS Lyu, Y Hu, CM Cultraro, ... Hepatology 52 (6), 2034-2043, 2010 | 154 | 2010 |
Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge AL Tarca, M Lauria, M Unger, E Bilal, S Boue, K Kumar Dey, J Hoeng, ... Bioinformatics 29 (22), 2892-2899, 2013 | 134 | 2013 |
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 Y Zhu, Y Liu, C Zhang, J Chu, Y Wu, Y Li, J Liu, Q Li, S Li, Q Shi, L Jin, ... Nature communications 9 (1), 1595, 2018 | 130 | 2018 |
Reactive animation: Realistic modeling of complex dynamic systems S Efroni, D Harel, IR Cohen Computer 38 (1), 38-47, 2005 | 112 | 2005 |
Using cellular automata modeling of the emergence of innovations J Goldenberg, S Efroni Technological Forecasting and Social Change 68 (3), 293-308, 2001 | 110 | 2001 |
Emergent dynamics of thymocyte development and lineage determination S Efroni, D Harel, IR Cohen PLoS computational biology 3 (1), e13, 2007 | 93 | 2007 |
Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis G Broderick, R Ben-Hamo, S Vashishtha, S Efroni, L Nathanson, Z Barnes, ... Brain, behavior, and immunity 28, 159-169, 2013 | 91 | 2013 |
Fmrp interacts with adar and regulates RNA editing, synaptic density and locomotor activity in zebrafish A Shamay-Ramot, K Khermesh, HT Porath, M Barak, Y Pinto, C Wachtel, ... PLoS genetics 11 (12), e1005702, 2015 | 89 | 2015 |
Reciprocal regulation between SIRT6 and miR-122 controls liver metabolism and predicts hepatocarcinoma prognosis S Elhanati, R Ben-Hamo, Y Kanfi, A Varvak, R Glazz, B Lerrer, S Efroni, ... Cell reports 14 (2), 234-242, 2016 | 88 | 2016 |
Predicting and affecting response to cancer therapy based on pathway-level biomarkers R Ben-Hamo, A Jacob Berger, N Gavert, M Miller, G Pines, R Oren, ... Nature communications 11 (1), 3296, 2020 | 82 | 2020 |
MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotype R Ben-Hamo, S Efroni Oncotarget 6 (3), 1594, 2015 | 72 | 2015 |
Reactive animation I Cohen, S Efroni, D Harel US Patent App. 10/542,591, 2006 | 72 | 2006 |
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer N Ben-Chetrit, D Chetrit, R Russell, C Koerner, M Mancini, A Abdul-Hai, ... Science Signaling 8 (360), ra7-ra7, 2015 | 71 | 2015 |
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer H Cohen, R Ben-Hamo, M Gidoni, I Yitzhaki, R Kozol, A Zilberberg, ... Breast Cancer Research 16, 1-16, 2014 | 68 | 2014 |